2010 Research Interest Groups (RIGS) Research Funding Opportunity (click here)

Meet the Experts:

• Social Security Disability: A Primer 
  Jamie R. Hall
• Are you getting phone calls about the "Liberation Treatment"?
  Alex-Rae Grant, MD
• What is an MS Centre? 
  Paul Rompani, MSIF; June Halper, CMSC/IOMSN; Eija Luto, RIMS

• Timed-Up and Go Test
• 25-Foot Walk Test
• 9-Hole Peg Test
  
  October 19, 2009 - These videos are courtesy of the International Organization of MS Rehabilitation Therapists.

Special Guidelines and Studies:

• October 26, 2010 - Patient Self-Management in MS (A White Paper Prepared by the CMSC)
• May 19, 2009-2009 Consortium of MS Centers MRI Protocol for the Diagnosis and Follow-up of MS

• January 21, 2010 - New Information about Oral Medication to Treat MS
  There is much to be excited about with recent news published January 20, 2010 in the New England Journal of Medicine (http://content.nejm.org/). You will find three articles which detail results from the Phase 3 studies of Novartis' Fingolimod (FTY720) and EMD Serono's Cladribine and an editorial by Dr. William M. Carroll, MB, BS, MD, FRACP.
• November 18, 2009 - American Brain Coalition ALERT
  Please join with other advocates nationwide to thank President Obama for his historic commitment to science provided by the American Recovery and Reinvestment Act and to urge him to make biomedical research a national priority by providing strong, sustained funding for the National Institutes of Health in FY 2011.
• November 2, 2009 - BAMS Bike Team Raises More Than $51,000 for MS Research
  NASHVILLE, TENN. – Band Against MS, Inc., (BAMS) is proud to announce their bike team raised $51,249 during the 2009 bike season, beating last year’s contribution by more than $26,000. Money raised goes toward furthering the goals of BAMS and the National Multiple Sclerosis Society (NMSS). BAMS, founded by multi-platinum recording artist Clay Walker, created the bike team as an extension of the artist’s charity to participate in rides across the country and to raise awareness of multiple sclerosis (MS).
• November 2, 2009 - Leading MS Lifestyle Empowerment Organization Changes Name
Edwards, CO – Can Do Multiple Sclerosis is the new name of the nation’s leading provider of lifestyle empowerment programs for people with multiple sclerosis (MS) and their support partners, announced Kim Sharkey, CEO, Can Do MS.

• February 5, 2010 - Tysabri (Natalizumab): Risk of developing progressive multifocal leukoencephalopathy (PML) increases with increasing duration of exposure to Tysabri
• February 3, 2010 - Acorda Therapeutics Announces Pricing and Patient Assistance Programs for Ampyra (dalfampridine)
• January 27, 2010 - Biogen Idec Moves Regenerative Medicine Drug into Human Trials
• January 25, 2010 - PROLOR Biotech Reports Positive Results From Comparative Study of Its Longer-Acting Version of Multiple Sclerosis Drug Interferon Beta in Primates
• January 22, 2010 - Acorda Therapeutics Announces FDA Approval of AMPYRA

• November 2009 Volume 13 Number 4

• Headache and MS: Learning from Each Other
  Daniel M Kantor, MD 
• The Role of the Social Worker in MS 
• The Role of the Social Worker in MS: Part I
  Roberta Winter, MSW, LCSW, MSCS
• The Role of the Social Worker As a Case Manager in MS
  Andrea Dowdall, MSW, MEd
• The Role of the Social Worker in MS: Part II
  Roberta Winter, MSW, LCSW, MSCS
• Domestic Violence - The Role of the Social Worker in MS
  Sherie Lammers, REACH Director, Trainer, NMSS
• Planning Ahead: Protecting Assets, Advance Directives, and Long-term Care
  Dorothy E. Northrop, MSW, ACSW, Vice President - Research & Clinical Operations, NMSS